Endogenous H2S Production Deficiencies Lead to Impaired Renal Erythropoietin Production.

Jennifer Leigh,Smriti Juriasingani,Masoud Akbari,Peng Shao,Manujendra N. Saha,Ian Lobb,Matthias Bachtler,Bernadette Fernandez,Zhongming Qian,Harry van Goor,Andreas Pasch,Martin Feelisch,Rui Wang,Alp Sener
DOI: https://doi.org/10.5489/cuaj.5658
2018-01-01
Canadian Urological Association Journal
Abstract:INTRODUCTIONPatients suffering from chronic kidney disease (CKD) experience a number of associated comorbidities, including anemia. Relative deficiency in renal erythropoietin (EPO) production is thought to be a primary cause of anemia. Interestingly, CKD patients display low levels of hydrogen sulfide (H2S), an endogenously derived renal oxygen sensor. Previous in vitro experiments have revealed that H2S-deficient renal cell lines produce less EPO than wild-type renal cell lines during hypoxia.METHODSWe postulated that H2S might be a primary mediator of EPO synthesis during hypoxia, which was tested using an in vivo murine model of whole-body hypoxia and in clinical samples obtained from CKD patients.RESULTSFollowing a 72-hour period of hypoxia (11% O2), partial H2S knockout mice (lacking the H2S biosynthetic enzyme cystathionine γ-lyase [CSE]) displayed lower levels of hemoglobin, EPO and cystathionine-β-synthase (CBS) (another H2S biosynthetic enzyme) compared to wild-type mice, all of which was rescued by exogenous H2S supplementation. We also found that anemic CKD patients requiring exogenous EPO exhibited lower urinary thiosulfate levels compared to non-anemic CKD patients of similar CKD classification.CONCLUSIONSTogether, our results confirm an interplay between the actions of H2S during hypoxia and EPO production.
What problem does this paper attempt to address?